Combining a newly formulated drug with one that is already a standard treatment slows the progression of multiple myeloma, an advanced cancer of the bone marrow cells, according to a clinical trial led by a University of North Carolina at Chapel Hill School of Medicine researcher.
In my extremely petite professional years, I have often heard the notion that in homoeopathic parlance, the sickness is basically the derangement of harmonious flow in the sensations of vital principle, whereby the disease producing micro-organisms and the likes of them are nothing- nihilist.
A monoclonal antibody developed by researchers at the University at Buffalo has been shown to extend significantly the survival of mice with human breast-cancer tumors and to inhibit the cancer’s spread to the lungs in the animals by more than 50 percent.
Despite the death of Pfizer’s new cholesterol drug, researchers say they are not abandoning their quest to find ways to prevent heart disease by raising levels of “good” cholesterol. Reducing LDL, or “bad” cholesterol, has been the main focus of cardiology in recent years, but boosting its counterpart, HDL, also has a salutary effect.
A new study suggests that a program focusing on increasing step length and speed is more effective at improving mobility and balance than tai chi. While tai chi — a Chinese martial art form consisting of slow, rotational movements and weight-shifting — offers many benefits, the researchers say, they’re not as great as those produced by a balance-training program.
Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, presented the final results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) at this year’s American Society of Hematology (ASH) meeting.
Thalidomide is a widely prescribed treatment for multiple myeloma. However, an estimated 15 to 30 percent of patients suffer venous thromboembolisms (VTEs), blood clots, as a major complication. The Bank On A Cure DNA-bank researchers have identified four gene clusters associated with the VTEs. Identifying the associated single nucleotide polymorphisms (SNPs) for use as markers, may lead to the development of screenings and tailored interventions to prevent these side effects, as a major step toward personalized medicine.
IMPDH is highly upregulated in most hematological cancers and solid tumors — an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function — believed to result in tumor cell apoptosis at the right doses.
A new study has found that close to half of 154 smokers who had surgery to remove early stage lung cancer picked up a cigarette again within 12 months of their potentially curative operation, and more than one-third were smoking at the one year mark. Sixty percent of patients who started smoking again did so within two months of surgery.
A symptom survey may provide clinicians with a rapid, cost-effective screening tool to detect early stages of ovarian cancer, according to a new study. The study reveals that early ovarian cancer may be distinguished from other causes by a specific set of symptoms and their frequency and duration.